Xiamen Ade Biological Technology Co., Ltd. (hereinafter referred to as "Ade Biological" or "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without any false records, misleading statements, or significant omissions.
I. Review Procedure
The 11th meeting of the 4th Board of Directors of Xiamen Ade Biological Technology Co., Ltd. was held on April 14, 2026, where the proposal on the profit distribution plan for 2025 was reviewed and approved. This proposal will be submitted to the Company's 2025 annual shareholders' meeting for consideration.